Oldest pages

Jump to navigation Jump to search

Showing below up to 50 results in range #241 to #290.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Class SR-2 gases‏‎ (19:18, 12 September 2019)
  2. Clearance level‏‎ (19:19, 12 September 2019)
  3. Clonogenic cells‏‎ (19:19, 12 September 2019)
  4. Clonogenic survival‏‎ (19:19, 12 September 2019)
  5. Co-expertise‏‎ (19:19, 12 September 2019)
  6. Colony‏‎ (19:20, 12 September 2019)
  7. Committed effective dose‏‎ (19:20, 12 September 2019)
  8. Committed equivalent dose‏‎ (19:20, 12 September 2019)
  9. Complex tissues‏‎ (19:21, 12 September 2019)
  10. Computed tomography dose index‏‎ (19:21, 12 September 2019)
  11. Connective tissue‏‎ (19:21, 12 September 2019)
  12. Consequential late effects‏‎ (19:21, 12 September 2019)
  13. Constancy test‏‎ (19:21, 12 September 2019)
  14. Contamination‏‎ (19:22, 12 September 2019)
  15. Coronary heart disease‏‎ (19:23, 12 September 2019)
  16. Cost-benefit analysis‏‎ (19:24, 12 September 2019)
  17. Coster-Kronig transition‏‎ (19:25, 12 September 2019)
  18. Curie‏‎ (19:25, 12 September 2019)
  19. Cytokines‏‎ (19:26, 12 September 2019)
  20. Decay constant‏‎ (19:28, 12 September 2019)
  21. Decommissioning‏‎ (19:28, 12 September 2019)
  22. Decontamination‏‎ (19:29, 12 September 2019)
  23. Decontamination factor‏‎ (19:29, 12 September 2019)
  24. Deontological Ethics‏‎ (19:30, 12 September 2019)
  25. Diastasis‏‎ (19:30, 12 September 2019)
  26. Dichotomous‏‎ (19:31, 12 September 2019)
  27. Differentiation‏‎ (19:31, 12 September 2019)
  28. In vivo radiobioassay‏‎ (19:32, 12 September 2019)
  29. Disposal‏‎ (19:33, 12 September 2019)
  30. DNA damage signalling‏‎ (19:33, 12 September 2019)
  31. Dose constraint‏‎ (19:35, 12 September 2019)
  32. Dose criteria‏‎ (19:35, 12 September 2019)
  33. Dose limit‏‎ (19:36, 12 September 2019)
  34. Dose per unit intake coefficient‏‎ (19:37, 12 September 2019)
  35. Dose rate‏‎ (19:38, 12 September 2019)
  36. Dose rate effectiveness factor‏‎ (19:38, 12 September 2019)
  37. Dose-rate effect‏‎ (19:39, 12 September 2019)
  38. Dose-threshold‏‎ (19:40, 12 September 2019)
  39. Early normal tissue responses‏‎ (19:43, 12 September 2019)
  40. Edema‏‎ (19:44, 12 September 2019)
  41. Effect Dose 50‏‎ (19:45, 12 September 2019)
  42. Effective charge number‏‎ (19:46, 12 September 2019)
  43. Effective dose equivalent‏‎ (19:47, 12 September 2019)
  44. Effective half-life‏‎ (19:49, 12 September 2019)
  45. Electron-capture decay‏‎ (19:49, 12 September 2019)
  46. Electrophysiology‏‎ (19:51, 12 September 2019)
  47. Emergency‏‎ (19:52, 12 September 2019)
  48. Emergency exposure situation‏‎ (19:52, 12 September 2019)
  49. Emergency plan‏‎ (19:53, 12 September 2019)
  50. Emergency preparedness‏‎ (19:53, 12 September 2019)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)